Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL
USFDA APPLICATION NUMBER - 22110
DOSAGE - POWDER;INTRAVENOUS - EQ 750MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL
USFDA APPLICATION NUMBER - 22110
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Taste Masking
Chewable & Orodispersible Aids
Direct Compression
Disintegrants & Superdisintegrants
Parenteral
Co-Processed Excipients
Solubilizers
Thickeners and Stabilizers
Granulation
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
87
PharmaCompass offers a list of Telavancin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Telavancin Hydrochloride manufacturer or Telavancin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Telavancin Hydrochloride manufacturer or Telavancin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Telavancin Hydrochloride API Price utilized in the formulation of products. Telavancin Hydrochloride API Price is not always fixed or binding as the Telavancin Hydrochloride Price is obtained through a variety of data sources. The Telavancin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 0701472ZG0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 0701472ZG0, including repackagers and relabelers. The FDA regulates 0701472ZG0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 0701472ZG0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 0701472ZG0 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 0701472ZG0 supplier is an individual or a company that provides 0701472ZG0 active pharmaceutical ingredient (API) or 0701472ZG0 finished formulations upon request. The 0701472ZG0 suppliers may include 0701472ZG0 API manufacturers, exporters, distributors and traders.
click here to find a list of 0701472ZG0 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 0701472ZG0 DMF (Drug Master File) is a document detailing the whole manufacturing process of 0701472ZG0 active pharmaceutical ingredient (API) in detail. Different forms of 0701472ZG0 DMFs exist exist since differing nations have different regulations, such as 0701472ZG0 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 0701472ZG0 DMF submitted to regulatory agencies in the US is known as a USDMF. 0701472ZG0 USDMF includes data on 0701472ZG0's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 0701472ZG0 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 0701472ZG0 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 0701472ZG0 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 0701472ZG0 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 0701472ZG0 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 0701472ZG0 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 0701472ZG0 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 0701472ZG0 suppliers with NDC on PharmaCompass.
0701472ZG0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 0701472ZG0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 0701472ZG0 GMP manufacturer or 0701472ZG0 GMP API supplier for your needs.
A 0701472ZG0 CoA (Certificate of Analysis) is a formal document that attests to 0701472ZG0's compliance with 0701472ZG0 specifications and serves as a tool for batch-level quality control.
0701472ZG0 CoA mostly includes findings from lab analyses of a specific batch. For each 0701472ZG0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
0701472ZG0 may be tested according to a variety of international standards, such as European Pharmacopoeia (0701472ZG0 EP), 0701472ZG0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (0701472ZG0 USP).
